Skip to main content
. 2019 May 31;14(5):e0217139. doi: 10.1371/journal.pone.0217139

Fig 4.

Fig 4

(A) Chromatographic profiles of PBTZ169 and metabolites in plasma collected in an healthy volunteer 30 minutes after the oral intake of 320 mg PBTZ169.HCl. (B) PK profile of PBTZ169 in plasma from the same volunteer, followed for 2 days after the administration of a single dose of 320 mg PBTZ169.HCl.